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Background: Determination of the fate of nanoparticles (NPs) in a biological system, or NP 
biodistribution, is critical in evaluating an NP formulation for nanomedicine. Current methods 
to determine NP biodistribution are greatly inadequate, due to their limited detection  thresholds. 
Herein, proof of concept of a novel method for improved NP detection based on in situ poly-
merase chain reaction (ISPCR), coined “nanobarcoding,” is demonstrated.
Methods: Nanobarcoded superparamagnetic iron oxide nanoparticles (NB-SPIONs) were char-
acterized by dynamic light scattering, zeta potential, and hyperspectral imaging  measurements. 
Cellular uptake of Cy5-labeled NB-SPIONs (Cy5-NB-SPIONs) was imaged by confocal 
microscopy. The feasibility of the nanobarcoding method was first validated by solution-phase 
PCR and “pseudo”-ISPCR before implementation in the model in vitro system of HeLa human 
cervical adenocarcinoma cells, a cell line commonly used for ISPCR-mediated detection of 
human papilloma virus (HPV).
Results: Dynamic light-scattering measurements showed that NB conjugation stabilized SPION 
size in different dispersion media compared to that of its precursor, carboxylated SPIONs (COOH-
SPIONs), while the zeta potential became more positive after NB  conjugation.  Hyperspectral imag-
ing confirmed NB conjugation and showed that the NB completely covered the SPION surface. 
Solution-phase PCR and pseudo-ISPCR showed that the expected amplicons were exclusively 
generated from the NB-SPIONs in a dose-dependent manner. Although confocal microscopy 
revealed minimal cellular uptake of Cy5-NB-SPIONs at 50 nM over 24 hours in individual 
cells, ISPCR detected definitive NB-SPION signals inside HeLa cells over large sample areas.
Conclusion: Proof of concept of the nanobarcoding method has been demonstrated in in vitro 
systems, but the technique needs further development before its widespread use as a standard-
ized assay.
Keywords: nanomedicine, in situ PCR, single cell, DNA-functionalized nanoparticles
Introduction
Nanomedicine is the application of nanotechnology toward the diagnosis and treatment 
of complex diseases. It involves the use of nanometer-sized particles (1–100 nm) that 
are precisely engineered to detect and monitor pathologies, deliver targeted therapy, 
or a combination of both modalities (“theragnosis” or “theranosis”) – all at the single-
cell level. In essence, nanoparticles (NPs) can be programmed to perform a controlled 
sequence of molecular functions, especially in regards to treating malignant cells. 
Here, NPs can be designed to release a therapeutic agent based on the extent of the 
disease state in the single cell, repair single cells at the molecular level, or induce 
 “unrepairable” single cells to perish by apoptosis. The multifunctional features of NPs 
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offer a continuous system to diagnose and treat diseases at 
the earliest possible stage, perhaps before symptoms actu-
ally appear.1,2
Given the extensive number of combinations possible 
on an engineered nanomedical system, it is obvious that any 
NP formulation possesses distinct physicochemical proper-
ties that influence their biological interaction with single 
cells and whole tissues. Moreover, the choice of route of 
administration, density, and dosage of NPs influences NP 
biodistribution profiles in targeted tissues and nontargeted 
systemic organs. There is a rapidly growing body of literature 
on the development of multifunctional NPs for theragnos-
tic purposes, but direct comparisons between in vitro and 
in vivo studies of similar NP types may not be possible 
due to the lack of standardization in study design and data 
reporting.3 Furthermore, current metrology to detect NPs is 
limited, making it difficult to evaluate NP biodistribution 
 accurately.3 Although NPs can be thoroughly characterized 
by their physicochemical properties, it remains difficult to 
predict NP biodistribution profiles and to assess such predic-
tions empirically.
Current NP detection techniques can be classified as 
either bulk-cell, in which large numbers of cells or whole 
tissues are scanned for the presence of NPs, or single-cell, 
in which individual cells are probed for positive NP uptake. 
Such analysis methods are often called “sample preserving,” 
since they maintain the structure of the biological samples 
for NP detection by imaging modalities, which is attractive 
for NP biodistribution studies, since spatial location and 
NP-induced effects can be evaluated.4 In contrast, there is 
also a special class of bulk-cell analysis methods – “sample-
destructive” – that analyzes NP amounts after processing the 
biological sample into cell lysates or tissue homogenates.4
Bulk-cell analysis employs imaging methods dependent 
on fluorescence labeling (eg, quantum dots),5,6 radiolabeling,7,8 
or magnetic cores9–11 to determine NP locations in large 
tissues. For example, Gultepe et al synthesized magnetic 
cationic liposomes that incorporate superparamagnetic iron 
oxide NPs (SPIONs) and studied in vivo biodistribution in 
tumor-bearing mice with a combination of magnetic reso-
nance imaging (MRI) and gamma counting of accumulated 
111In-labeled magnetic cationic liposomes in systemic organs 
after sacrifice.12 In another approach, Haglund et al prepared 
peptide-targeted fluorescent quantum dots, directly injected 
them into SkBr3 breast cancer tumors in athymic mice, 
and analyzed histological tissue sections by fluorescence 
microscopy.13 In both instances, NPs can only be detected 
when they are present in large aggregates/agglomerates, or 
in other words, above the detection threshold of the fluo-
rescence microscope, which is bound by the wavelength of 
light. Individual NPs are suboptical and can only be detected 
when they are aggregated or agglomerated in large numbers. 
Additionally, it is difficult to associate NP uptake with cell 
type, especially within histological tissue sections, due to the 
relatively large screening area and poor imaging resolution 
in bulk-cell analysis.
On the other hand, single-cell analysis techniques are 
ultrasensitive, with the capability of detecting small num-
bers of NPs in individual cells. These methods include 
flow cytometry (also known as fluorescence-activated cell 
sorting),14–17 electron microscopy (EM),18–20 and so-called 
super-resolution microscopy.21–24 For example, scanning EM 
(SEM) and transmission EM (TEM) are common methods 
for imaging NP uptake in vitro and ex vivo. Gupta et al25 and 
Gupta and Gupta26 showed the accumulation of SPIONs at the 
cell surface by SEM and the location of SPIONs inside single 
human fibroblasts by TEM. Even though these techniques 
can resolve and detect small numbers of NPs associated with 
individual cells, they are not practical for large-scale biodis-
tribution studies, especially in regards to ex vivo analysis of 
systemic organs. Unless one knows where to look for NPs, 
analysis of NP biodistribution in this manner is extremely 
tedious and time-consuming.
As mentioned previously, there is also a special class of 
bulk-cell analysis techniques that requires the destruction 
of the biological sample before measuring the presence of 
NPs. Mass spectrometry, most notably inductively coupled 
plasma mass spectrometry,27–29 has been employed success-
fully in quantifying small amounts of NPs due to its very 
low detection limits (parts per trillion to parts per million). 
Field-flow fractionation is a separation technique that is 
gaining ground in quantifying NPs in biological analytes,30 
given the possibility of coupling with mass spectrometry. In 
addition, chromatography, notably high-performance liquid 
chromatography, has been used to identify, quantify, and 
purify NPs present in cell lysates and tissue homogenates.31–34 
Although these sample-destructive techniques are sensitive 
enough to detect single NPs in cell lysates and tissue homo-
genates, these techniques assume that the cells in the original 
biological samples were homogeneous, meaning that every 
cell takes up an equal fraction of the measured NP amount. 
Usually, the NP quantification is normalized by starting 
cell number and/or cellular protein mass, classifying these 
 methods as analyses at the bulk-cell level. This makes it dif-
ficult to discern whether the measured NP amount stemmed 
from small, homogeneous NP uptake from all cells or large 
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NP uptake within a small subpopulation of cells.35 Likewise, 
these techniques do not discriminate between internalized 
NPs and NPs fused to the outside of the cell membrane, 
because spatial information is lost.
In light of the current limitations, there is an obvious 
need for more sensitive and more efficient methods that 
(1) detect and measure small numbers of NPs of various 
types, ideally single NPs; (2) associate preferential NP uptake 
with histological cell type by preserving spatial information 
in samples; and (3) allow for relatively quick and accurate NP 
detection in in vitro and ex vivo samples for whole-body NP 
biodistribution studies. To achieve all of these specifications 
currently, one needs to perform complementary methods. 
For example, fluorescence microscopy (after fluorescence 
labeling) and TEM can be used in tandem for determining 
the cellular uptake efficiency and intracellular locations, 
respectively, of SPION conjugates.
One method that has the potential to fulfill the require-
ments of an improved NP detection strategy is in situ poly-
merase chain reaction (ISPCR). ISPCR combines the extreme 
sensitivity of PCR and the cell-localizing ability of in situ 
hybridization, and has been utilized for rapid detection of 
HIV-1 in CD4+ cells and human papilloma virus (HPV) in 
epithelial tumor tissue.36 In ISPCR, cells or tissue sections 
are fixed and digested on glass slides to allow for penetra-
tion of PCR amplification cocktail inside single cells. Using 
specific primers, the gene of interest can be amplified in situ 
(inside the cell) with labeled nucleotides or primers, and the 
labeled PCR products, or amplicons, can then be detected 
using enzyme-linked antibodies that specifically bind to the 
labeled nucleotides and produce a colorimetric product (after 
exposure to a substrate) that can be visualized using a stan-
dard light microscope, or if fluorescently labeled nucleotides 
are used, direct imaging under a fluorescence microscope.37,38 
The colorimetric or fluorescent signal generated by ISPCR 
provides the abilities to optically identify single cells carrying 
specific genes of interest in a tissue section and to correlate 
cellular genotype to aspects of normal or pathological tissue 
morphologies.
Since ISPCR has had success in detecting viral DNA at 
a low copy number inside single cells, which is analogous 
to the small numbers of NPs that can be present, the ISPCR 
technique can be adapted to the detection of single NPs 
inside cells. Thus, a novel method for single NP detection 
was conceived that incorporates a nonendogenous oligo-
nucleotide (oligo, henceforth) on the NP surface for use as a 
unique “nanobarcode” (NB).39–41 After the nanobarcoded NPs 
 (NB-NPs) are internalized by cells, the NB serves as a forward 
primer during ISPCR-mediated signal  amplification inside 
the cells of fixed samples. As amplicons are generated, they 
drift away from the NP, forming a radius of labeled ISPCR 
products or amplicons that can be detected at the optical level 
(Figure 1A). One can quickly determine which individual 
cells in several biological samples contain internalized NPs, 
facilitating the quantification/qualification of NP uptake 
and the application of specific assays on the NP-positive 
cell subpopulation (Figure 1B). For the preliminary detec-
tion scheme, the development of optical signal is based on 
digoxigenin (DIG), which is a commonly used colorimetric 
detection system in in situ hybridization. A DIG-based detec-
tion system is advantageous over other detection systems 
(eg, biotin-streptavidin labeling), since DIG is derived from 
the foxglove plant and is not present in mammalian tissues, 
reducing nonspecific signals due to endogenous products.36 
Figure 2 shows a depiction of the NB system on an NP.
In this paper, proof of concept of the nanobarcoding 
method was demonstrated using SPIONs as the model NP 
type. First, NB-SPIONs were synthesized and characterized 
by size, zeta potential, and hyperspectral imaging measure-
ments. The nanobarcoding method was then tested in cell-free 
Figure 1 Depiction of detection of nanobarcoded nanoparticles (NB-NPs) by in situ polymerase chain reaction (ISPCr) in single cells and whole tissues. (A) NB-NPs present 
inside a single cell (gray circles) are subjected to ISPCR, and the resulting labeled amplicons form a radius of colorimetric or fluorescent signal around each NP, which is visible 
at the optical level (green circles) (B) Single cells exhibiting the colorimetric or fluorescent signal (green circles) are easily identifiable within a cell monolayer or histological 
tissue section, denoting the presence of NB-NPs within those cells.
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and cell-based systems, with the latter using HeLa (human 
cervical adenocarcinoma) as the in vitro model system.
Materials and methods
Cell culture
HeLa human cervical adenocarcinoma cells (American Type 
Culture Collection [ATCC], Manassas, VA) were cultured in 
Eagle’s minimum essential medium (EMEM) supplemented 
with 10% (v/v) fetal bovine serum (ATCC). Before SPION 
treatment, the medium was changed to Opti-MEM I reduced 
serum media (Life Technologies, Carlsbad, CA). All cells 
were maintained in T25 tissue-culture flasks at 37°C with 
5% CO
2
/95% ambient air and subcultured every 3–4 days to 
maintain exponential growth.
NB-SPION synthesis
Water-soluble, carboxylated (COOH) SPIONs (10 nm core 
size measured by TEM) were acquired from Ocean NanoTech 
(Springdale, AK) and used as purchased. SPIONs (1 mg, 
0.86 nmol Fe) were diluted in 0.22 mL of nanograde water. 
SPIONs were activated with 0.1 mL 1-ethyl-3-(3-dimethyl-
aminopropyl) carbodiimide (∼10 mM)/sulfo-N-hydroxy-
sulfosuccinimide (∼5 mM) solution for 10 minutes with 
continuous vortexing at room temperature. Activated SPIONs 
were diluted with 0.5 mL of nanograde water and 5′-amine-







CAC GGG GTC TAA CAC TAT CGC T-3′ (Integrated DNA 
Technologies [IDT], Coralville, IA) was added at 10 × molar 
excess (8.6 nmol) to a final reaction volume of 1 mL. For 
cellular uptake studies, 5′-amine modified NB with a 3′-Cy5 
label (IDT) was conjugated to the COOH-SPIONs. The solu-
tion was allowed to react for 24 hours at room temperature 
with continuous vortexing. The reactions were quenched by 
addition of 20 mM final concentration of Tris-HCl in nano-
grade water (pH 7.0). The NB-SPIONs were washed three 
times with nanograde water via magnetic separation at 4°C 
and then diluted to 1 mg/mL stock concentration.
NB-SPION characterization
Size (hydrodynamic diameter by dynamic light scattering 
[DLS]) measurements were taken using the Zetasizer Nano 
ZS (Malvern Instruments, Malvern, UK). COOH-SPIONs 
and NB-SPIONs were diluted to 20 µg/mL in nanograde 
water, phosphate-buffered saline (PBS), Opti-MEM I, or 
serum-free EMEM and transferred to a disposable folded 
capillary cell for analysis by the Zetasizer Nano ZS. Three 
measurements were taken at room temperature (25°C) using 
the Zetasizer Nano software’s automatic mode to choose the 
appropriate settings for run length and number of runs per 
measurement. For size, the Z-averages are reported. The 
Z-average is the intensity weighted mean hydrodynamic size 
of the ensemble collection of particles, which is derived from 
cumulants analysis of the dynamic light scattering measured 
intensity autocorrelation function.
For hyperspectral imaging analysis, COOH-SPIONs 
and NB-SPIONs were diluted to 250 µg/mL in nanograde 
water. Free NB was diluted to 100 µM in nanograde water. 
Samples were submitted to CytoViva (Auburn, AL) for 
spectral analysis using the CytoViva Hyperspectral Imaging 
System. The mean spectral curves from each sample were 
used to characterize the surface chemistry on the NPs. To 
determine how much of the SPION surface was covered 
with conjugated NB, the spectral mapping function in the 
CytoViva Hyperspectral Image Analysis software was 
applied with respect to the NB spectral library.
Solution-phase PCr of NB-SPIONs
To test the feasibility of ISPCR, solution-phase PCR was first 
performed on the NB-SPION suspension and  supernatant. 
The supernatant, after magnetically isolating the NB- 
SPIONs, was included in PCR reactions to demonstrate 
that the PCR products, or amplicons, were derived from 
conjugated NB and not free NB remaining in the SPION 
suspensions. A synthetic 99-nt single-stranded (ssDNA) 
DNA oligo was used as the amplification template (5′-AAG 
Figure 2 Depiction of nanobarcoded nanoparticles (NB-NP). (A) NB is conjugated to the surface of NPs; (B) the NB will anneal to a complementary, nonendogenous ssDNA 
“template;” (C) polymerase chain reaction amplification generates amplicons labeled with digoxigenin (DIG)-labeled deoxyuridine triphosphate; (D) anti-DIg horse radish 
peroxidase antibodies bind to DIg-labeled amplicons, and a colorimetric product is formed upon exposure to diaminobenzidine substrate by horseradish peroxidase.
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CAC GGG GTC TAA CAC TAT CGC TCG AAG GAC GTC 
CGT CGA TGC TAA GTT CCT AGA TTT ATA GCG CAT 
TCC CGT TTA GGG ATC TAC GTT AAG GCT-3′), and a 
corresponding synthetic 27-nt reverse primer (5′-AGC CTT 
AAC GTA GAT CCC TAA ACG GGA-3′) only amplified 
the complementary strand of the template after the first 
round of PCR (IDT). The NB (forward primer) and reverse 
primer were checked for nonspecificity for endogenous DNA 
sequences via BLAST (National Center for Biotechnology 
Information, Bethesda, MD).
Before NB-SPIONs can be applied to and detected 
in cells, it is wise to check for nontargeted amplification 
of genomic DNA by the conjugated NB. The model in 
vitro system for testing the in situ PCR-based detection 
method is HeLa, a human cervical cancer cell line often 
used to optimize in situ PCR conditions for detection of 
HPV. Thus, genomic DNA should be extracted from HeLa 
cells and subjected to solution-phase PCR against the NB. 
HeLa cells were grown in a T75 cell culture flask to ∼90% 
confluence and harvested via trypsin treatment. The cells 
were centrifuged and washed twice with cold PBS and 
resuspended to a final concentration of 107 cells/mL in cold 
PBS. Using the Blood and Cell Culture Mini Kit (Qiagen, 
Valencia, CA), the cells were lysed and protease digested 
before purification and elution of genomic DNA from an 
anion-exchange resin column. The HeLa genomic DNA 
was then precipitated after the addition of isopropanol and 
quantified using the NanoDrop 2000 (Thermo Fisher Scien-
tific, Waltham, MA). About 250 ng of HeLa genomic DNA 
was loaded into solution-phase PCR reactions with 10.5 µg 
NB-SPIONs (HeLa genomic DNA served as template). To 
check the integrity of the extracted DNA, primers (2.5 µM 
final concentration) for the HPV18 E7 (172 bp amplicon; 
forward 5′-CCG AGC ACG ACA GGA GAG GCT-3′, reverse 
5′-TCG TTT TCT TCC TCT GAG TCG CTT) and β-actin 
(99 bp amplicon; forward 5′-CCA CAC TGT GCC CAT CTA 
CG-3′, reverse 5′-AGG ATC TTC ATG AGG TAG TCA GTC 
AG-3′) were used to amplify corresponding regions in the 
HeLa genomic DNA.42
Solution-phase PCR was performed in a Thermo Hybaid 
Sprint Thermal Cycler PCR machine (Thermo Fisher 
Scientific) using 12.5 µL 2X GoTaq Colorless Master Mix 
(containing 400 µM deoxynucleotide triphosphate and 3 mM 
MgCl
2
, (Promega, Madison, WI), 1 µM reverse primer, 
200 ng amplification template, NB-SPION suspension 
(1, 3, or 6 µg) or supernatant (1, 3, or 6 µL). Nuclease-
free water was added to a final PCR reaction volume of 
25 µL. For positive and negative amplification controls, 
either 1 µM free NB or 6 µL DNase-free water was added 
instead of SPION suspension or supernatant, respectively. 
After 1 minute of denaturation at 94°C, PCR amplification 
was then carried out in 30 cycles of 30 seconds at 94°C, 
30 seconds at 55°C, and 1 minute at 72°C. In the last cycle, 
the elongation step at 72°C was prolonged to 5 minutes. 
The PCR reactions were then cooled to 4°C. Amplicons 
were detected by agarose gel electrophoresis using a 2% 
Divbio Synergel Agarose Additive (BioExpress, Kaysville, 
UT)/0.7% agarose gel with 0.5 µg/mL ethidium bromide 
(EtBr) in 1 × Tris-acetate-EDTA buffer (Sigma-Aldrich, St 
Louis, MO). NB-SPIONs (10 µg) that were not subjected 
to PCR were also loaded into the gel as a nonamplification 
control. Agarose gel electrophoresis was run at 50 V for 
2 hours, and the gel was imaged under ultraviolet light using 
the Gel Documentation System (Bio-Rad, Hercules, CA). 
Semiquantitative analysis of band densities (also known 
as intensity peak size) was performed using ImageJ’s Gel 
Analysis Tool.
Cellular uptake of NB-SPIONs
HeLa cells were seeded at 5 × 104 cells per cm2 onto 18 mm 
glass coverslips placed in a 12-well tissue-culture plate. 
After incubating at 37°C/5% CO
2
 overnight, cells were 
washed three times with PBS before the addition of Cy5-
NB-SPIONs at 50 nM and 25 nM final concentrations in 
Opti-MEM I Reduced Serum Media. After 24-hour incuba-
tion at 37°C/5% CO
2
, cells were washed three times with 
PBS and fixed in 4% (w/v) paraformaldehyde in PBS for 
10 minutes. After washing in PBS, cells were permeabilized 
with 0.1% (v/v) Triton X-100 in PBS for 5 minutes. After 
blocking cells in 1% (w/v) bovine serum albumin (BSA) 
in PBS for 20 minutes, the cells were stained with Alexa 
Fluor 488 phallotoxin (F-actin in cytoskeleton, 5 µL per 
coverslip) and Hoechst 33342 (cell nuclei, 2 µg/mL final) 
(Life Technologies) in PBS for 20 minutes. Coverslips were 
mounted onto glass microscope slides using VectaShield 
Mounting Medium for Fluorescence (Vector Labs, 
Burlingame, CA). Cells were imaged for Cy5 (Ex/Em 
648/668), Alexa Fluor 488 phallotoxin (Ex/Em 488/499), 
and Hoechst 33342 (Ex/Em 350/461) at 60 × magnification 
on a Nikon A1R confocal microscope (Nikon Instruments, 
Melville, NY).
Pseudo-ISPCr of NB-SPIONs
To determine if NB-SPIONs can be detected inside 
single cells by ISPCR, “pseudo”-ISPCR was performed, 
in which NB-SPIONs were applied to cells after fixation 
and  pretreatment to eliminate issues associated with NP 
 incubation with live cells. HeLa cells in a T25 culture flask 
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(∼1 × 106 cells) were washed in PBS, harvested, and seeded 
onto sterile APTES (3-aminopropyltriethoxysilane)-treated 
glass slides at 40,500 cells/25 µL in two 0.81 cm2 areas per 
slide (5 × 104 cells per cm2), which were delineated with a 
hydrophobic Pap-Pen. Cells were seeded on the delineated 
areas and allowed to dry under sterile conditions. After 
incubation, the cells were washed in PBS and fixed in 4% 
paraformaldehyde in PBS for 30 minutes at 4°C. After 
washing three times in PBS, the cells were permeabilized 
with 0.1% (v/v) Triton X-100 in PBS for 5 minutes and 
then deproteinized with proteinase K (Sigma-Aldrich) in 
PBS for 10 minutes at room temperature. Deproteiniza-
tion was stopped by washing cells in a 0.2% (w/v) gly-
cine in PBS, and then the cells were postfixed in ice-cold 
ethanol for 10 minutes. Endogenous peroxidase activity was 




 in PBS for 
10 minutes at room temperature and then washing quickly 
in PBS and then water. Frame-Seal Incubation Chambers 
(Bio-Rad) were applied to each cell area on the slide (two 
per slide). The ISPCR cocktail was prepared containing 
15 µL 2 × GoTaq Colorless Master Mix (Promega), 200 nM 
amplification template, 2.5 µM reverse primer, 20 µM DIG-
tagged deoxyuridine triphosphate (DIG-dUTP) (1:10 DIG-
dUTP:deoxythymidine triphosphate [dTTP] ratio), 0.1% 
(w/v) BSA, and varying amounts of NB-SPIONs (0.5, 1, 2, 
5, or 10 µg). Nuclease-free water was added to a final PCR 
reaction volume of 30 µL. For the negative ISPCR control, 
nuclease-free water was added in lieu of NB-SPIONs. For 
the positive ISPCR controls, free NB (2.5 µM final) was used 
in lieu of NB-SPIONs, and HPV18 E7 or β-actin primers 
were used in lieu of all NB reagents as “internal” positive 
controls. After heating the cocktails to 80°C, the cocktails 
were layered over the cells and then sealed using a plastic 
coverslip. The slides were then placed on the GeneAmp 
In Situ PCR System 1000 (PerkinElmer, Waltham, MA), 
which was preheated to 80°C. After 2 minutes of initial 
denaturation at 94°C, PCR amplification was then carried 
out in 30 cycles of 1 minute at 94°C, 1 minute at 55°C, 
and 1 minute at 72°C. In the last cycle, the elongation step 
at 72°C was prolonged to 5 minutes. The slides were then 
cooled to 4°C.
After thermocycling, the amplification cocktail was 
collected from the surface of cells for analysis by agarose 
gel electrophoresis. The slides were then washed three 
times in PBS for 5 minutes each. Nonspecific sites were 
blocked by incubating the slides 1% (w/v) BSA in 50 mM 
Tris-HCl/300 mM NaCl (blocking buffer) for 30 minutes. 
 Anti-DIG antibody from sheep, Fab fragments, conjugated 
with polymerized horse radish peroxidase ([POD] Roche 
Applied Science, Indianapolis, IN) was added to blocking 
buffer at 1.5 U/mL final concentration. The slides were 
incubated in the antibody solution for 1 hour at room tem-
perature and then washed three times with Tris-HCl/NaCl 
buffer for 10 minutes each. The POD substrate, diamino-
benzidine (DAB), was diluted in peroxide buffer (Roche 
Applied Science), and the slides were incubated with the 
DAB working solution until cells developed a purple-brown 
color. The slides were washed in water, dried, and mounted 
in VectaShield Mounting Medium. Bright-field images 
of cell samples were obtained with a Nikon Eclipse 80i 
microscope (Nikon Instruments) equipped with a MicroPub-
lisher 5.0 RTV camera (QImaging, Surrey, BC, Canada) at 
20 × magnification.
ISPCr-mediated detection  
of NB-SPIONs
HeLa cells were seeded at 5 × 104 cells/cm2 in a T25 tis-
sue culture flask or multiwell tissue-culture plates. After 
incubating at 37°C/5% CO
2
 overnight, cells were washed 
three times with PBS before the addition of NB-SPIONs 
in Opti-MEM I Reduced Serum Media (Life Technolo-
gies, Carlsbad, CA). After 24 hours incubation at 37°C/5% 
CO
2
, the cells were washed three times with PBS before 
harvesting by  trypsinization. Cells were centrifuged and 
then washed with PBS before counting. Cellular smears 
(40,500 cells/25 µL) were fixed and pretreated as described 
for pseudo-ISPCR. The ISPCR cocktail was prepared con-
taining 15 µL 2 × GoTaq Colorless Master Mix, 200 nM 
amplification template, 2.5 µM reverse primer, 20 µM 
 DIG-dUTP (1:10 DIG-dUTP:dTTP ratio), and 0.1% (w/v) 
BSA. Nuclease-free water was added to a final ISPCR 
reaction volume of 30 µL. For the negative ISPCR control, 
nuclease-free water was added in lieu of amplification 
template and reverse primer. Similarly, HPV18 E7 primers 
were used for positive ISPCR controls. ISPCR cocktails 
were added to cellular smears and sealed with Frame-Seal 
Incubation Chambers. ISPCR thermocycling conditions, rev-
elation procedures, and imaging protocols were performed 
as described for pseudo-ISPCR.
Statistical analysis
Statistical significance between COOH- and NB-SPION 
data (size and zeta potential) was computed using Microsoft 
Excel’s (Microsoft Corporation, Redmond, WA) Student 
t-test function (two-tailed, two-sample unequal variance) 
using α = 0.05.
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Results
NB-SPION characterization
Figure 3 displays size and zeta potential measurements 
for COOH- and NB-SPIONs dispersed in different media. 
A significant increase in Z-average diameter was observed 
after NB conjugation when measured in nanograde water 
and PBS (P , 0.05). In general, the Z-average diameter 
increases and the zeta potential becomes more positive when 
the dispersion medium is composed of more solvent mole-
cules (eg, counterions, amino acids) that can adsorb to the 
surface of the NPs. The adsorption of counterions and amino 
acids (eg, l-glutamine) to the surface of oligo-functionalized 
NPs has been observed previously.43,44 NP agglomeration is 
known to occur to some extent in biological and environ-
mental solutions,45 and Opti-MEM I and serum-free EMEM 
induce the formation of COOH-SPION agglomerates that 
are micron-sized. In contrast, the Z-average diameter of the 
NB-SPIONs remained in the nanoscale (Figure 3A). It is 
hypothesized that the increase in zeta potential, attributed 
to the conjugated NB, stabilizes the SPION size in different 
dispersion media. The NP surface becomes more negatively 
charged and attracts more positively charged counterions 
and/or amino acids to form a thicker boundary layer around 
the NP, resulting in a more positive zeta potential. The 
zeta potentials are most negative when the SPIONs are 
dispersed in nanograde water and most positive when the 
SPIONs are dispersed in serum-free EMEM, which was 
expected  (Figure 3B). The zeta potentials of the COOH- and 
 NB-SPIONs were statistically different in all dispersion 
media (P , 0.05). The difference is most apparent when the 
SPIONs were dispersed in nanograde water (−62.43 mV for 
COOH-SPIONs and −32.27 mV for NB-SPIONs).
Hyperspectral imaging analysis was performed to confirm 
NB conjugation to the SPION surface. Figure 4A shows the 
mean spectral responses of COOH- and NB-SPIONs. The 
x-axis units are in wavelength in nm, and the y-axis units 
are counts of the relative intensity of the reflectance scatter 
within the spectral data. The peak intensity of NB-SPIONs is 
much lower than that of COOH-SPIONs, indicating that the 
light-scattering properties of NB-SPIONs were reduced. In 
general, metallic and metal oxide NPs experience a similar 
reduction in their reflectance peak when new chemistry is 
introduced onto the NPs (Leslie Krauss, CytoViva, email 
communication, May 31, 2012). These data show that NB has 
been successfully conjugated onto the surface of the COOH-
SPIONs. To determine how much of the SPION surface was 
covered with conjugated NB, the spectral mapping function 
in the CytoViva Hyperspectral Image Analysis Software was 
applied, referencing the NB spectral library (Figure 4B). Each 
pixel in the hyperspectral scan of NB-SPIONs (Figure 4C) 
that matches the NB spectral library is pseudo-colored red, 
and the results show that the NB seems to coat the SPION 
entirely (Figure 4D).
Solution-phase PCr of NB-SPIONs
An image of the agarose gel is shown in Figure 5A. The 
upper band seen in most of the lanes represents 99-bp 
double-stranded DNA (dsDNA) amplicons, and the lower 
one is unamplified template, which is ssDNA. The identity 
of the upper band is confirmed by the positive amplification 
control of free NB in lane 8. The identity of the lower band 
is confirmed from the negative amplification control (water) 
in lane 7. As apparent in lanes 1–3, the amplification of the 
conjugated NB increases with the SPION amount added to 
the PCR reaction (Figure 5B). No amplicons were generated 
from the supernatants, as seen in lanes 4–6. Retention of 
the NB-SPIONs can be observed as thin fluorescent bands 
















































































Figure 3 Size (A) and zeta potential measurements (B) of carboxylated (COOh) 
and nanobarcoded (NB) superparamagnetic iron oxide nanoparticles (SPIONs) in 
different dispersion media. 
Note: Asterisks indicate significant difference between NB-SPION and COOH-
SPION samples in the same medium (P , 0.05).
Abbreviations: EMEM, Eagle’s minimum essential medium; PBS, phosphate-
buffered saline.
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Figure 4 (A) Mean spectral responses of nanobarcoded superparamagnetic iron oxide nanoparticles (NB-SPIONs) (red trace) and carboxylated (COOh) SPIONs (white trace). 
(B) NB spectral library that was used to map pixels in the hyperspectral microscopy image of NB-SPIONs (C), pseudo-color red (D), indicating the presence of NB on the 
SPION surface.
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Figure 5 Agarose gel electrophoresis of nanobarcoded superparamagnetic iron oxide nanoparticle (NB-SPION) suspension and supernatants. (A) gel image: lane L, DNA 
ladder; lanes 1–3, polymerase chain reactions (PCr) with NB-SPIONs (1, 3, or 6 µg); lanes 4–6, PCrs with SPION-free supernatant (1, 3, or 6 µL); lane 7, PCr reactions 
without NB (negative water control); lane 8, PCr reactions with free NB (positive control); lane 9, 10 µg NB-SPIONs (nonamplification control). The 100-bp band has been 
indicated for reference. (B) Semiquantitative analysis of intensity peak size of 99 bp and 99 nt bands by ImageJ.
Since positive EtBr staining is observed and EtBr preferen-
tially stains nucleic acids, this indicates the presence of NB 
conjugated to the NP surface. The fluorescence intensity from 
the retained NB-SPIONs increases with increasing SPION 
volume added to the PCR reaction. Although the NB-SPIONs 
were retained in the wells of the agarose gel, the electropho-
retic mobility of the amplicons was not hindered.
PCR performed against HeLa genomic DNA yielded 
no detectable amplicons, even for PCR reactions contain-
ing free NB and reverse primer. However, positive-control 
primers for HPV18 E7 and β-actin generated the expected 
amplicons (172 bp and 99 bp, respectively), indicating that 
the extracted DNA was of high integrity (data not shown). 
This demonstrates that the NB does not amplify nonspecific 
sequences in HeLa genomic DNA. Thus, detection via this 
NB sequence would be restricted to NB-SPIONs.
Cellular uptake of NB-SPIONs
Cellular uptake studies were performed to investigate 
whether the in vitro model cell type, HeLa, was able to 
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internalize NB-SPIONs despite their extremely negative 
zeta potential and the absence of a cell-targeting ligand, as 
demonstrated in previous studies of oligonucleotide-func-
tionalized gold and iron oxide NPs.46–48 To determine if the 
NB-SPIONs are bound to the outside of cell membranes or 
actually internalized in cells, Cy5-labeled NB (3′ end) was 
conjugated to SPIONs to provide a means of fluorescence-
mediated tracking. NB-SPION doses for confocal micros-
copy are based on elemental iron content of the NB-SPIONs 
(0.86 nmol/mg). Fluorescence confocal microscopy of 
HeLa cells treated with Cy5-NB-SPIONs show that some 
Cy5-NB-SPIONs are found inside the cells at 50 and 25 nM 
(Figure 6A and B, respectively) concentrations over a 24-hour 
incubation period, although most of the Cy5-NB-SPIONs 
were found on top of the cells (as seen in the cellular cross 
sections to the right and bottom of Figure 6A and B).
Pseudo-ISPCr of NB-SPIONs
To show that the nanobarcoding method can be used to 
detect NB-SPIONs inside HeLa cells, pseudo-detection of 
NB-SPIONs by ISPCR was performed. The term “pseudo” 
means that the cells were not incubated with NB-SPIONs 
pre-ISPCR; instead, the NB-SPIONs were simply included 
in the ISPCR cocktail. Performing ISPCR in this manner 
eliminates any uncontrollable variables that are related to 
the effects of NP interaction with living cells. Panels A–E 
in Figure 7 show that the DAB signal intensity is directly 
proportional to the amount of NB-SPIONs present in the 
ISPCR cocktail, which was expected. NB-SPIONs at 10 µg 
exhibited the strongest signal, while NB-SPIONs at 0.5 µg 
exhibited the weakest signal. These extremes in DAB signal 
intensity were comparable to the signal intensities of panel F 
(free NB) and panel G (water), respectively. Interestingly, the 
DAB signal intensities from the “internal” positive controls of 
HPV18 E7 and β-actin (panels H and I) were not as intense 
as those arising from 10, 5, and 2 µg NB-SPIONs (panels 
A–C) and even that of the free NB (panel F).
ISPCr-mediated detection  
of NB-SPIONs
The first ISPCR experiment with HeLa cells incubated with 
NB-SPIONs resulted in all samples exhibiting positive DAB 
samples, including the negative water control. When the 
supernatants were electrophoresed on an agarose gel, all of 
the lanes had prominent smears that were not observed in pre-
vious control ISPCR experiments (data not shown). To avoid 
false positives in direct ISPCR, some groups suggest using 
only cellular smears or cytospin preparations, performing the 
hot-start ISPCR procedure, and avoiding the application of 
dry heat on the samples.36,49,50 All of these suggestions have 
been followed in this experiment, as well as the previous 
control experiments. Two observations – positive signal in 
the negative control and DNA smears in the gel – point to 
NP-induced DNA damage as the culprit. The smears on the 
gel are most likely due to damage of genomic DNA induced 
by the NB-SPIONs,51 and the false positives are most likely 
related to nonspecific incorporation of DIG-dUTP into the 
nicks and gaps in genomic DNA by primer-independent Taq 
polymerase- and cycling-dependent “DNA repair.” Thus, the 
short-term solution in avoiding false positives is to perform 
ISPCR twice: to repair nicks and gaps in genomic DNA 
first before attempting to detect the NB-SPIONs. This was 
done by using only GoTaq Colorless Master Mix diluted in 
nuclease-free water (no primers, no template, and especially 
no DIG-dUTP) in the first round, and using the usual ISPCR 
cocktail in the second round. This strategy was successful in 
differentiating between the positive and negative controls, 
as it eliminated the false-positive problem.
Figure 8 shows ISPCR samples that were incubated with 
(A) 50 nM, (B) 5 nM, (C) 500 pM, or (D) no NB-SPIONs 
Figure 6 Confocal microscopy images of Cy5-labeled nanobarcode conjugated to superparamagnetic iron oxide nanoparticles (Cy5-NB-SPIONs) inside heLa cells with cross 
sections (bottom and right of images). (A) 50 nM Cy5-NB-SPIONs; (B) 25 nM Cy5-NB-SPIONs; (C) untreated control.
Notes: green, Alexa Fluor 488 phallotoxin (F-actin); blue, hoechst 33342 (nuclei); red, Cy5-NB-SPIONs. Scale bars are 10 µm.
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Figure 7 Pseudo-in situ polymerase chain reaction performed with nanobarcoded superparamagnetic iron oxide nanoparticles (NB-SPIONs). (A) 10 µg NB-SPIONs; 
(B) 5 µg NB-SPIONs; (C) 2 µg NB-SPIONs; (D) 1 µg NB-SPIONs; (E) 0.5 µg NB-SPIONS; (F) 2.5 µM free NB; (G) hPV18 E7; (H) β-actin; (I) water. 
Note: Scale bar is 100 µm.
Figure 8 In situ polymerase chain reaction (ISPCr) on samples that were incubated with nanobarcoded superparamagnetic iron oxide nanoparticles at (A) 50 nM, (B) 5 nM, 
(C) 500 pM, or (D) 0 final concentrations for 24 hours.
Notes: ISPCr cocktails contain reverse primer and template (1), hPV18 E7 primers (2), or water (negative control) (3). Scale bar is 100 µm.
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and assayed for (1) NB, (2) HPV18 E7, and (3) nonspecific 
background (water). The control samples produced the 
expected results. Panels D1 and D3 did not produce intense 
DAB signals. In panel D2, the HPV18 E7 produced intense 
DAB signals and the expected 172-bp amplicons, which 
were validated by agarose gel electrophoresis (data not 
shown). The ISPCR samples that were incubated with #5 nM 
 NB-SPIONs (B1 and C1) appear negative when compared 
to their corresponding negative controls (B3 and C3). 
 However, the ISPCR sample that was incubated with 50 nM 
NB-SPIONs (panel A1) appears to exhibit some DAB signal 
intensity over background (panel A3).
Since incubation with 50 nM NB-SPIONs produced a 
visually detectable DAB signal, the next ISPCR experiment 
was performed with NB-SPION concentrations clustered 
around 50 nM (Figure 9). It appears that 24-hour incuba-
tion with NB-SPIONs at concentrations $50 nM generates 
a visually detectable DAB signal (Figure 9A and B; data 
for 100 nM concentration not shown). However, it is sur-
prising that the intensity of the DAB signal appears similar 
at both 50 nM and 200 nM, although the presence of the 
 NB-SPIONs is more pronounced in the higher-concentration 
sample (orange coloration in Figure 9A). It is speculated 
that 50 nM may be the saturation point for the NB system 
as it is designed.
Discussion
Understanding the biodistribution of NPs is critical for the safe, 
effective application of nanomedicine. Current approaches to 
study NP biodistribution have been hampered by a large gap 
in existing NP detection methods: NPs can either be detected 
in small amounts in single cells (single-NP, single-cell) or in 
substantial agglomerates over relatively large areas of biologi-
cal sample (bulk-NP, bulk-cell). To characterize the biological 
interactions of a given NP formulation, complementary NP 
detections need to be performed to gain a comprehensive 
picture. However, NP-induced effects are often difficult to 
evaluate as a function of the number of cell-associated NPs, 
because multiplexed studies are not informative enough due 
to the aforementioned threshold limitations. Such studies 
are instead expressed as a function of NP dose, which does 
not provide much information about the safety and effective-
ness of NP components. This rationale paved the way for the 
development of the nanobarcoding method to close the gap 
between existing NP detection methods (single-NP, bulk-
cell) and to facilitate a means for linking actual intracellular 
NP concentration to NP-induced effects.
This work demonstrates proof of concept of the nano-
barcoding method. The feasibility of the nanobarcoding 
method was first demonstrated in cell-free systems. Solution-
phase PCR of NB-SPIONs reveals specific amplification by 
the conjugated NB, and amplicons were allowed to migrate 
through the gel during electrophoresis. This demonstrates the 
ability of the amplicons to “drift away” from the NB-SPIONs, 
which is the key to creating the radius of amplified signal 
necessary for detection inside cells. Moreover, the conjugated 
NB does not amplify nonspecific sequences in genomic DNA 
from HeLa, the cell line that served as the in vitro model in 
this work, indicating that any observed signals are restricted 
to NB-SPIONs.
Figure 9 In situ polymerase chain reaction (ISPCr) on samples that were incubated with nanobarcoded superparamagnetic iron oxide nanoparticles at (A) 200 nM, 
(B) 50 nM, (C) 25 nM, or (D) 0 final concentrations for 24 hours. The same ISPCR cocktail (containing reverse primer and template) was used for these samples. Control 
ISPCr samples were performed with (E) human papilloma virus 18 E7 primers or (F) water.
Note: Scale bar is 100 µm.
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Despite these positive results, validation of the nano-
barcoding method in cell-based systems was challenging. 
NB-SPIONs appeared to induce some DNA damage, since 
nonspecific signals were seen in ISPCR samples in which the 
reverse primer and template were omitted. It was speculated 
that the DIG-dUTP was incorporated into nicks and gaps in 
the damaged DNA, producing the high background signals. 
The short-term solution was to perform ISPCR thermocy-
cling twice: the first time for Taq-mediated DNA repair and 
the second time for actual NB amplification. This solution 
helped differentiate between the positive HPV18 E7 and 
β-actin controls and the negative water control and allowed 
the NB-SPION detection signals to emerge. However, the 
current NB-SPION concentrations were too high to consider 
the observed threshold as single-NP detection, but further 
development beyond these feasibility studies may be able 
to improve the sensitivity. Nevertheless, these results rep-
resent a major advance in the difficult area of determining 
NP biodistributions at single-cell levels. The nanobarcoding 
method has been shown to rapidly detect NPs over relatively 
large areas with apparently greater sensitivity than confo-
cal microscopy over smaller areas. This is demonstrated by 
comparing the ISPCR (Figures 8A1 and 9B) and confocal 
microscopy  (Figure 6A) results for NB-SPIONs at 50 nM 
concentration over a 24-hour exposure period.
Although the basic feasibility of the nanobarcoding 
method has been confirmed, the sensitivity of the current 
design restricts its power in detecting small numbers of NPs 
inside single cells. Comparing the results from the pseudo-de-
tection experiment to the actual ISPCR results provides some 
possible explanations for the lack of sensitivity seen thus far. 
Pseudo-detection of NB-SPIONs by ISPCR represents the 
desired results of the nanobarcoding method: the intensity 
of DAB signal is correlated with the amount of NB-SPIONs 
present. However, these results were not replicated in actual 
ISPCR experiments. The major difference between these two 
sets of experiments is applying the NB-SPIONs postfixation 
versus prefixation of the ISPCR samples. Nuclease activity 
within the cells is speculated to have a detrimental effect on 
NB integrity. Other possible reasons for the lack of sensitivity 
are inadequacies in the NB system itself, such as deficient 
NB conjugation, inefficient cellular uptake, and limitations 
in NB signal amplification.
Moreover, the ISPCR results need to be validated 
by complementary NP detection methods. Agarose gel 
electrophoresis of the ISPCR supernatants was performed 
after each ISPCR experiment, but the expected amplicons 
were never detected, even though a detection signal was 
observed in the cells (data not shown). In contrast, the 
expected amplicons for the HPV18 E7 and β-actin positive 
controls were always detected in both ISPCR and agarose 
gel electrophoresis. Since the SPION core is electron-dense, 
TEM, which is considered the gold standard in single-cell NP 
detection, should be performed after ISPCR experiments on 
NB-SPION-treated samples to approximate the amount of 
NB-SPIONs inside each cell. This is a logical choice, since 
many protocols have been written on performing ISPCR 
directly on TEM grids.52,53
The primary goal of future work should be increasing the 
sensitivity of NP detection. To our knowledge, there are two 
approaches to improving the sensitivity of the nanobarcoding 
method: (1) target amplification by optimizing NB on the 
NP itself; and (2) signal amplification by augmenting the 
design of the ISPCR protocol. For the first approach, there are 
multiple ways to amplify the “target,” which can be defined 
as higher amounts of conjugated NB per NP and/or higher 
amounts of internalized NPs per cell to increase the detec-
tion signal. First, the NP uptake efficiency can be improved 
by adding targeting ligands (eg, antibodies, peptides) to 
the NP surface54 or maximizing the density of the NB on 
the NP surface by using different conjugation chemistries 
and/or reaction schemes.47,55 The former option will definitely 
decrease the potential density of the NB on the NP surface 
(and subsequently signal amplification), but will provide the 
option of targeted cellular uptake. The latter option may also 
help guard against digestion by endogenous nucleases.43,56 
However, the NB may still be susceptible to some level of 
nuclease digestion to the point where it no longer resembles 
a functioning PCR primer. The simplest way to increase 
nuclease stability is to make the NB double-stranded via 
hybridization to a complementary oligo, since dsDNA is 
generally more stable than ssDNA.57 Other ways of increasing 
nuclease stability involve applying chemical modifications 
most commonly used in the synthesis of antisense oligos. 
Examples include phosphorothioate, 2-O-methoxyethyl, 
2-O-methyl, locked nucleic acid, morpholina, and peptide 
nucleic acid.58–61 However, it is not known if these chemical 
modifications can be introduced into the NB without hinder-
ing its function as a PCR primer.
The second approach, signal amplification, involves aug-
menting the design of the ISPCR protocol. Currently, revela-
tion of ISPCR amplicons is mediated by direct DIG detection 
with POD-linked antibodies and DAB substrate. The most 
obvious way to amplify the detection signal from ISPCR 
amplicons is to switch over to indirect DIG detection with 
primary antibodies against DIG- and POD-linked secondary 
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antibodies. Indirect detection is more sensitive, since each 
primary antibody can recruit many secondary antibodies 
for a more intense signal. Another way is to utilize different 
enzymes (eg, alkaline phosphatase) and/or chromogenic 
substrates that may be more sensitive and less interfering 
than DAB (eg, nitroblue-tetrazolium salt or Fast Red 1–5-
naphethediol in combination with 5-bromo-4- chloro-3 indo-
lyl-phosphate).62 In addition, fluorescence-based detection 
can be used with tyramide signal amplification,50 which has 
been shown to amplify the detection signal on the order of 
500- to 1000-fold when compared to biotin-avidin.63–65
Besides the revelation procedure, another possible way 
to amplify the detection signal is by lowering the final con-
centrations of the reverse primer and template in the ISPCR 
cocktail. This may provide more operational NB:reverse 
primer and NB:template ratios since the effective concentra-
tion of NB may be relatively low due to the small number 
of NB-NPs present inside the cells. In addition, the cell’s 
architecture already limits the interactions between the NB, 
reverse primer, template, and especially the large Taq poly-
merase molecules. Thus, lowering the concentrations of these 
reagents may facilitate increased diffusion throughout the 
cellular architecture, which ensures more targeted amplicon 
production.66
Increasing the sensitivity of the nanobarcoding method 
has been stressed throughout this work, but improvements 
can also be made toward its specificity. Recall that the NB-
SPIONs induced nicks and gaps in genomic DNA, allowing 
the incorporation of DIG-dUTP, which consequently gener-
ated high background signals. The short-term solution was 
performing ISPCR to repair the damaged DNA first and 
then again to generate NB amplicons. However, this made 
the sample more susceptible to injury, since the total number 
of heating cycles and the total time spent above 90°C were 
doubled. To work around these issues, a combination of PCR 
and in situ hybridization (PCR-ISH), also known as indirect 
ISPCR, can be used instead of ISPCR. Here, the detection is 
based on ISH of a labeled probe to the amplicons, in which 
revelation occurs in a sequence-specific manner. Although 
this method is theoretically less sensitive than ISPCR, there 
is less worry about nonspecific signals and sample damage. 
Furthermore, future efforts toward improving the sensitivity 
of the current ISPCR protocol could also help to improve the 
sensitivity threshold of PCR-ISH.
In addition to improving the specificity of the nano-
barcoding method, PCR-ISH would permit the simultaneous 
detection of more than one NP type in the same sample. In 
fact, the term “nanobarcoding” itself implies the encoding 
of information on an NP. The information that can be gained 
is the amounts and locations of certain NPs based on the 
color and intensity of the amplified NP detection signal. For 
example, two NP types are nanobarcoded with unique NB 
sequences. After administration of these NPs, samples are 
harvested and prepared for PCR-ISH. After PCR-ISH, the 
samples are examined for the expected detection signals from 
each NP type. Depending on the application, the effects of 
physicochemical properties, targeting mechanisms, route of 
entry, and nanotoxicity can be studied simultaneously in one 
sample set. This allows for systematic evaluation of several 
NP parameters in a reduced sample size with the potential for 
less measurement error. Essentially, multiple NP biodistribu-
tion experiments can be performed on a single animal.
Since NP biodistribution studies are often performed 
in vivo, the possibility of ex vivo analysis of excised tissues 
and organs is quite advantageous. It is often difficult to cor-
relate NP dose and administration route to preferential accu-
mulation in relevant tissues or even distinct cell types within 
those tissues. Thus, future work should look into applying 
nanobarcoding to NP detection ex vivo in tissues. The basic 
steps of the nanobarcoding method are still applicable to 
ex vivo samples, but the required optimizations for tissue 
sections increase the overall complexity of the procedure. 
Ex vivo samples can be (1) fixed and then frozen or embed-
ded in paraffin or (2) frozen and then fixed. In addition, the 
deproteinization step needs to be optimized for each tissue 
type, since the sample is no longer relatively uniform as it is 
in vitro. Moreover, other factors need to be considered, such 
as DNA integrity during tissue processing, presence of Taq 
polymerase inhibitors, and reduced retention of amplicons 
due to the loss of intact cell membranes. This stresses the 
importance of improving the sensitivity of the nanobarcod-
ing method before tackling NP detection in ex vivo samples. 
Still, the use of the nanobarcoding method ex vivo would 
make it a disruptive technology that has the potential to 
qualify in vivo NP biodistribution on a single-cell level.
In summary, the power of the nanobarcoding method 
will be realized when its sensitivity and specificity can be 
optimized. First, the sensitivity of NP detection needs to be 
improved by applying the principles of both target and signal 
amplification. Second, the specificity can be increased by the 
introduction of a post-PCR hybridization step (PCR-ISH), 
which would allow for simultaneous detection of more than 
one NP type in a single biological sample. Finally, these 
improvements would pave the way for precise analysis of in 
vivo NP biodistribution via ex vivo samples, which would be 
the ultimate utility of the nanobarcoding method.
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Conclusion
Today, nanomedicine is expanding the possibilities of con-
trolling and monitoring complex diseases. NPs, the instru-
ments of nanomedicine, are being developed at a rapid pace, 
with innovative formulations that are often programmed to 
perform a specific order of functions at the molecular level. 
However, some of the anticipated benefits of nanomedicine 
are hyped, due to the lack of predictive models for in vitro 
and in vivo NP behavior. This work endeavored to facilitate 
the establishment of such models through the development 
of the nanobarcoding method, which has the potential to 
track small numbers or even single NPs for improved NP 
biodistribution studies at the single-cell level. Herein, proof 
of concept of the nanobarcoding method has been demon-
strated, but the technique needs further development before 
its widespread use as a standardized assay.  Notwithstanding, 
the wealth of knowledge that can be gained from nanobarcod-
ing has the potential to aid current NP design efforts and 
redefine regulatory science such that potentially life-saving 
NP formulations can be realized.
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